Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

MANILA, Philippines — The National Bureau of Investigation (NBI) is prepared to find out who spread the claim that Ombudsman Jesus Crispin Remulla was hospitalized during the holidays and eventually ...

MANILA, Philippines — Ombudsman Jesus Crispin Remulla on Thursday assured the public that his health is in its best condition, while also disputing what he called a false narrative claiming that he ...

Ombudsman Jesus Crispin Remulla has asked the National Bureau of Investigation to look into social media posts claiming that he was hospitalized. In his first press conference for the year 2026, ...

Finland's National Bureau of Investigation (NBI) has seized the Fitburg to secure its preliminary investigation. The cargo vessel is suspected of damaging a submarine cable in the Gulf of Finland.

SARAH DISCAYA / SEPTEMBER 1, 2025 Contractor Sarah Discaya at the Senate session hall in Pasay City in this file photo taken on September 1, 2025. INQUIRER PHOTO / NINO JESUS ORBETA MANILA, ...

The National Bureau of Investigation (NBI) filed a new plunder complaint against former Ako Bicol Party-List Representative Zaldy Co with the Department of Justice (DOJ) on Monday. “We have one ...

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective at the close of trading on Friday, ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Sub‑100-ms APIs emerge from disciplined ...

On Monday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) said its Phase 2 study of NBI-1070770 in adults with major depressive disorder did not meet the primary endpoint compared to placebo, though it ...

Another of the psychiatry drugs Neurocrine Biosciences licensed from Takeda has stumbled in the clinic. The latest midstage flop comes from NBI-1070770, a negative allosteric modulator of the NR2B ...

SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational ...